Tursi V - Search Results

1

Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation.

Baraldo M, Cojutti PG, Isola M, Feruglio MT, Tursi V, Livi U, Furlanut M. Baraldo M, et al. Among authors: tursi v. Transplant Proc. 2009 Dec;41(10):4277-84. doi: 10.1016/j.transproceed.2009.08.077. Transplant Proc. 2009. PMID: 20005384

2

C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses.

Baraldo M, Francesconi A, Barbone F, Tursi V, Livi U, Furlanut M. Baraldo M, et al. Among authors: tursi v. Transplant Proc. 2002 Dec;34(8):3246-8. doi: 10.1016/s0041-1345(02)03699-0. Transplant Proc. 2002. PMID: 12493435 No abstract available.

3

Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients.

Baraldo M, Isola M, Feruglio MT, Francesconi A, Franceschi L, Tursi V, Livi U, Furlanut M. Baraldo M, et al. Among authors: tursi v. Transplant Proc. 2005 Jun;37(5):2240-3. doi: 10.1016/j.transproceed.2005.03.090. Transplant Proc. 2005. PMID: 15964387 Clinical Trial.

4

The clinical risk in heart transplantation: is it evaluable?

Guzzi G, Maiani M, Aresu G, Tursi V, Spagna E, Livi U. Guzzi G, et al. Among authors: tursi v. Transplant Proc. 2011 Jan-Feb;43(1):307-10. doi: 10.1016/j.transproceed.2010.09.108. Transplant Proc. 2011. PMID: 21335211

5

Heart transplantation in patients with neoplastic disease.

Caforio AL, Tursi V, Brombin M, Feltrin G, Angelini A, Livi U. Caforio AL, et al. Among authors: tursi v. Transplant Proc. 1998 Aug;30(5):1928. doi: 10.1016/s0041-1345(98)00528-4. Transplant Proc. 1998. PMID: 9723337 No abstract available.

6

Cyclosporine-based steroid-free therapy in pediatric heart transplantation: long-term results.

Livi U, Caforio AL, Gambino A, Tursi V, Milanesi O, Stellin G, Angelini A, Casarotto D. Livi U, et al. Among authors: tursi v. Transplant Proc. 1998 Aug;30(5):1975-6. doi: 10.1016/s0041-1345(98)00501-6. Transplant Proc. 1998. PMID: 9723358 No abstract available.

7

Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia.

Pea F, Cojutti P, Tursi V, Livi U, Baraldo M. Pea F, et al. Among authors: tursi v. Transpl Infect Dis. 2015 Dec;17(6):926-8. doi: 10.1111/tid.12446. Epub 2015 Oct 28. Transpl Infect Dis. 2015. PMID: 26296391 No abstract available.

8

Donor age greater than 50 years does not influence midterm results of heart transplantation.

Livi U, Caforio AL, Tursi V, Boffa GM, Borrelli MR, Bauce B, Thiene G, Casarotto D. Livi U, et al. Among authors: tursi v. Transplant Proc. 1996 Feb;28(1):91-2. Transplant Proc. 1996. PMID: 8644352 No abstract available.

9

Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection.

Dall'Amico R, Montini G, Murer L, Andreetta B, Tursi V, Feltrin G, Guzzi G, Angelini A, Zacchello G, Livi U. Dall'Amico R, et al. Among authors: tursi v. Transplant Proc. 1997 Feb-Mar;29(1-2):609-11. doi: 10.1016/s0041-1345(96)00323-5. Transplant Proc. 1997. PMID: 9123152 Clinical Trial. No abstract available.

10

Long-term decrease in subjective perceived efficacy of immunosuppressive treatment after heart transplantation.

Cherubini P, Rumiati R, Bigoni M, Tursi V, Livi U. Cherubini P, et al. Among authors: tursi v. J Heart Lung Transplant. 2003 Dec;22(12):1376-80. doi: 10.1016/s1053-2498(03)00023-8. J Heart Lung Transplant. 2003. PMID: 14672752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters